EUVIMEDEUVIMED entdecken
Crossref

Letter regarding Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

Jashin J. Wu

Journal of Psoriasis and Psoriatic Arthritis · 2016

DOI: 10.1177/247553031600100201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Psoriasis and Psoriatic Arthritis, 2016. Verfasst von Jashin J. Wu. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wu, J. J. (2016). Letter regarding Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis. Journal of Psoriasis and Psoriatic Arthritis. https://doi.org/10.1177/247553031600100201

Vancouver

Wu JJ. Letter regarding Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis. Journal of Psoriasis and Psoriatic Arthritis. 2016. doi:10.1177/247553031600100201

BibTeX
@article{Wu2016,
  author = {Wu, Jashin J.},
  title = {Letter regarding Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis},
  journal = {Journal of Psoriasis and Psoriatic Arthritis},
  year = {2016},
  doi = {10.1177/247553031600100201}
}
Kostenlos starten →